HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Stefan Buchholz Selected Research

gastrin releasing peptide (14-27)

7/2012Combination of gastrin-releasing peptide antagonist with cytotoxic agents produces synergistic inhibition of growth of human experimental colon cancers.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Stefan Buchholz Research Topics

Disease

23Neoplasms (Cancer)
10/2020 - 07/2006
18Breast Neoplasms (Breast Cancer)
11/2018 - 07/2006
5Triple Negative Breast Neoplasms
11/2014 - 07/2009
3Colonic Neoplasms (Colon Cancer)
11/2012 - 10/2009
2Cardiogenic Shock
01/2022 - 11/2017
2Neoplasm Metastasis (Metastasis)
10/2020 - 12/2016
2Acute Coronary Syndrome
01/2018 - 11/2017
2Atrophy
06/2014 - 04/2014
2Prostatic Neoplasms (Prostate Cancer)
01/2012 - 12/2008
2Carcinoma (Carcinomatosis)
08/2010 - 09/2006
1False Aneurysm (Pseudoaneurysm)
11/2021
1Heart Failure
12/2018
1Ischemia
01/2018
1Myocardial Infarction
01/2018
1Pericardial Effusion
12/2016
1Disease Susceptibility (Diathesis)
01/2016
1Multiple Myeloma
11/2015
1Infections
08/2015
1Atrophic Vaginitis
06/2014
1Takotsubo Cardiomyopathy
07/2013
1Heart Block
10/2012
1Pathologic Constriction (Stenosis)
10/2012
1Rare Diseases (Rare Disease)
09/2011
1Aortic Dissection
09/2011
1Colorectal Neoplasms (Colorectal Cancer)
08/2010

Drug/Important Bio-Agent (IBA)

9Growth Hormone-Releasing Hormone (Somatotropin Releasing Hormone)IBA
11/2012 - 09/2006
8Estrogens (Estrogen)FDA Link
11/2018 - 11/2008
5Aromatase InhibitorsIBA
11/2018 - 01/2010
5PhAcTyr(1)- Arg(2)- P(H)e(4- CL)(6)- Ala(8)- Tyr(Me)(10)- His(11)- Abu(15)- His(20)- Nle(27)- Arg(28)- HLCr(29)- GHRH(1-29)NH2IBA
11/2012 - 02/2007
4TamoxifenFDA LinkGeneric
11/2018 - 01/2010
4Hormones (Hormone)IBA
01/2015 - 04/2008
4Gonadotropin-Releasing Hormone (GnRH)FDA Link
11/2014 - 07/2006
4Somatostatin (Somatotropin Release-Inhibiting Factor)IBA
02/2013 - 07/2006
4Messenger RNA (mRNA)IBA
06/2010 - 07/2006
3Doxorubicin (Adriamycin)FDA LinkGeneric
11/2014 - 08/2009
3ErbB Receptors (EGF Receptor)IBA
09/2012 - 02/2007
3BombesinIBA
07/2012 - 07/2006
3Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
01/2012 - 12/2008
3Proteins (Proteins, Gene)FDA Link
12/2008 - 07/2006
2Estrogen ReceptorsIBA
11/2018 - 11/2008
2exemestane (Aromasin)FDA Link
07/2018 - 01/2015
2ProgesteroneFDA LinkGeneric
12/2016 - 07/2009
2Estriol (Epiestriol)IBA
06/2014 - 04/2014
2Somatostatin Receptors (Somatostatin Receptor)IBA
02/2013 - 08/2009
2Cytotoxins (Cytolysins)IBA
11/2012 - 07/2012
2Irinotecan (Camptosar)FDA LinkGeneric
11/2012 - 07/2012
2Fluorouracil (Carac)FDA LinkGeneric
11/2012 - 07/2012
2Gastrin-Releasing PeptideIBA
07/2012 - 11/2007
2AndrogensIBA
01/2012 - 12/2008
2somatotropin releasing hormone receptorIBA
01/2012 - 07/2009
2RC 121IBA
08/2010 - 08/2009
2Anastrozole (Arimidex)FDA LinkGeneric
05/2010 - 01/2010
2Peptides (Polypeptides)IBA
08/2009 - 07/2006
2MZ-J-7-138IBA
12/2008 - 09/2006
2Docetaxel (Taxotere)FDA Link
02/2007 - 09/2006
1Polyethylene Terephthalates (Polyethylene Terephthalate)IBA
11/2021
1Interleukin-6 (Interleukin 6)IBA
10/2020
1Antidepressive Agents (Antidepressants)IBA
01/2016
1fas Receptor (CD95 Antigen)IBA
08/2015
1TabletsIBA
06/2014
1Vaginal Creams, Foams, and Jellies (Vaginal Tablet)IBA
06/2014
1Estrogen Receptor alphaIBA
04/2014
1Estradiol (Delestrogen)FDA LinkGeneric
04/2014
1Protein Isoforms (Isoforms)IBA
09/2013
1G-Protein-Coupled Receptor Kinase 5IBA
07/2013
1Adrenergic Receptors (Adrenergic Receptor)IBA
07/2013
1N- (2- diethylaminoethyl)- N- (2- hydroxy- 2- phenylethyl)- 2,5- dichloroanilineIBA
02/2013
1Cisplatin (Platino)FDA LinkGeneric
11/2012
1CD3 ComplexIBA
09/2012
1Indicators and Reagents (Reagents)IBA
09/2012
1ertumaxomabIBA
09/2012
1Immunoglobulins (Immunoglobulin)IBA
09/2012
1AntibodiesIBA
09/2012
1Complement System Proteins (Complement)IBA
09/2012
1human ERBB2 proteinIBA
09/2012
1Hca(6)-Leu(13)-psi(CH2N)-Tac(14)- bombesin(6-14)IBA
07/2012
1gastrin releasing peptide (14-27)IBA
07/2012
1Progesterone Receptors (Progesterone Receptor)IBA
04/2012
1Epidermal Growth Factor (EGF)IBA
04/2012
1LHRH Receptors (Gonadotropin-Releasing Hormone Receptor)IBA
04/2012
1TOR Serine-Threonine KinasesIBA
01/2012
1Phosphotransferases (Kinase)IBA
01/2012
1Trastuzumab (Herceptin)FDA Link
09/2011
1Monoclonal AntibodiesIBA
09/2011
1Lapatinib (GW572016)FDA Link
09/2011
1pertuzumabIBA
09/2011

Therapy/Procedure

12Therapeutics
07/2018 - 07/2006
5Drug Therapy (Chemotherapy)
07/2018 - 02/2007
3Heart Transplantation (Grafting, Heart)
01/2022 - 10/2011
2Transplantation
01/2022 - 01/2018
2Extracorporeal Membrane Oxygenation
11/2021 - 11/2017
2Prostheses and Implants (Prosthesis)
11/2021 - 10/2012
2Percutaneous Coronary Intervention
01/2018 - 11/2017
1Stents
11/2021
1Treatment Delay
01/2018
1Sternotomy
12/2016
1Cardiopulmonary Bypass (Heart-Lung Bypass)
12/2016
1Lymphatic Irradiation
11/2015
1Bioprosthesis
10/2012
1Castration
01/2012